|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|LILLY||Antifolate combination therapies|| |
(1 year, 4 months ago)
Alimta is owned by Lilly.
Alimta contains Pemetrexed Disodium.
Alimta has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Alimta are:
Alimta was authorised for market use on 04 February, 2004.
Alimta is available in powder;intravenous dosage forms.
The generics of Alimta are possible to be released after 24 May, 2022.
Market Authorisation Date: 04 February, 2004
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic